<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The study was undertaken to determine a possible association of <z:chebi fb="46" ids="15035">retinal</z:chebi> vascular lesion in <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> (SLE) with the <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> (APS) </plain></SENT>
<SENT sid="1" pm="."><plain>A hundred and ninety-four patients (160 females and 34 males, whose mean age was 30.7+/-8.9 years) with verified SLE were examined </plain></SENT>
<SENT sid="2" pm="."><plain>Group I comprised 67 patients with <z:chebi fb="46" ids="15035">retinal</z:chebi> vascular lesions (Subgroup la (n = 13) with <z:chebi fb="46" ids="15035">retinal</z:chebi> <z:e sem="disease" ids="C1096458" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">vascular occlusions</z:e> and Subgroup 1b (n = 54) without occlusions) </plain></SENT>
<SENT sid="3" pm="."><plain>Group 2 included 127 patients without <z:chebi fb="46" ids="15035">retinal</z:chebi> vascular lesions </plain></SENT>
<SENT sid="4" pm="."><plain>APS was detected in 86 patients </plain></SENT>
<SENT sid="5" pm="."><plain><z:chebi fb="46" ids="15035">Retinal</z:chebi> <z:e sem="disease" ids="C1096458" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">vascular occlusions</z:e> more frequently occurred in patients with APS (13.9%) than in those without APS (0.9%) (p = 0.0009) and more frequently in patients with APS and <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> (24.3%) than in those with APS without <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> (6.1%) (p = 0.0359) </plain></SENT>
<SENT sid="6" pm="."><plain>Extraocular thromboses were more frequently encountered in Subgroup 1a (69.2%) than in Subgroup 1b (33.3%) (p = 0.0399) and in Group 2 (22.8%), (p = 0.0010) </plain></SENT>
<SENT sid="7" pm="."><plain>Cerebral <z:mpath ids='MPATH_105'>circulatory disorder</z:mpath> (CCD) was observed in 30.7% in Subgroup la, in 14.8% in Subgroup 1b, and in 7.9% in Group 2 (p = 0.0268) </plain></SENT>
<SENT sid="8" pm="."><plain><z:hpo ids='HP_0002326'>Transient ischemic attack</z:hpo> (<z:hpo ids='HP_0002326'>TIA</z:hpo>) occurred in 46.2% in Subgroup la, in 24.1% in Subgroup 2a, and in 14.9% in Group 2 (p = 0.0129) </plain></SENT>
<SENT sid="9" pm="."><plain><z:hpo ids='HP_0001873'>Thrombocytopenia</z:hpo> was identified in 69.2% in Subgroup 1a, in 22.2% in Subgroup 2a (p = 0.0021), and in 12.6% in Group 2 (p &lt; 0.0000) </plain></SENT>
<SENT sid="10" pm="."><plain>The frequency of elevated IgG of anticadiolipin (aCL) in Subgroup 1a (80%) exceeded that in Subgroup 1b (37.9%) (p = 0.0309) and Group 2 (30.7%) (p = 0.0096) </plain></SENT>
<SENT sid="11" pm="."><plain>Another isotype of aCL (IgM 80%) was observed in patients with <z:chebi fb="46" ids="15035">retinal</z:chebi> <z:e sem="disease" ids="C1096458" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">vascular occlusions</z:e>, but the differences in this index were insignificant in the groups and subgroups </plain></SENT>
<SENT sid="12" pm="."><plain>The association of pathological changes in <z:chebi fb="46" ids="15035">retinal</z:chebi> vessels in the presence of <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> (LA) was particularly noticeable (91.7 and 52% in Subgroup la and Subgroup 1b, respectively (p = 0.0191) and 47.1% in Group 2 (p = 0.0088) </plain></SENT>
<SENT sid="13" pm="."><plain>There was an association of <z:hpo ids='HP_0100576'>amaurosis fugax</z:hpo> with eyeground occlusions (p &lt; 0.004), CCD and <z:hpo ids='HP_0002326'>TIA</z:hpo> (p &lt; 0.0002), APS (p &lt; 0.0003), and essential <z:hpo ids='HP_0000822'>hypertension</z:hpo> (p &lt; 0.05) </plain></SENT>
<SENT sid="14" pm="."><plain>Thus, occlusive lesions in the fundus of the eye are a common manifestation of thrombogenesis in SLE in the presence of APS </plain></SENT>
<SENT sid="15" pm="."><plain>The frequency of concomitance of <z:chebi fb="46" ids="15035">retinal</z:chebi> <z:e sem="disease" ids="C1096458" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">vascular occlusions</z:e> with cerebral <z:mpath ids='MPATH_105'>circulatory disorders</z:mpath> should be referred to as severe manifestations of SLE </plain></SENT>
<SENT sid="16" pm="."><plain><z:e sem="disease" ids="C0376288" disease_type="Disease or Syndrome" abbrv="">Amaurosis</z:e> fugas is a manifestation of <z:chebi fb="46" ids="15035">retinal</z:chebi> vascular lesion and associated with the presence of APS and elevated blood pressure in patients with SLE </plain></SENT>
<SENT sid="17" pm="."><plain>There is an association of an occlusive process in the fundus of the eye with different symptoms of APS and primarily with IgG of aCL, LA, and <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> </plain></SENT>
</text></document>